Cargando…
Lurasidone as a potential therapy for bipolar disorder
Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute treatment of adults with schizophrenia (October 2010) and bipolar 1 depression (June 2013). Lurasidone has a strong antagonistic property at the D(2), serotonin (5-HT...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797281/ https://www.ncbi.nlm.nih.gov/pubmed/24143101 http://dx.doi.org/10.2147/NDT.S51910 |